Drug lookup
Drug reference

Podophyllotoxin

Topoisomerase Inhibitor · Treatment of anogenital warts

Topoisomerase InhibitorTreatment of anogenital warts
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
Not absorbed from skin, but manufacturer advises avoid.
FDA category + note

Mechanism

Podophyllotoxin binds to tubulin at the colchicine-binding site, inhibiting microtubule assembly and arresting cells in mitosis. However, its semisynthetic derivatives etoposide and teniposide have a completely different mechanism — they inhibit topoisomerase II rather than tubulin. Applied topically for genital warts, podophyllotoxin causes necrosis of condylomata through its antimitotic effect on the rapidly proliferating HPV-infected epithelium.

Indications

Condylomata acuminata affecting the penis or the female external genitalia

Dosing

Adult
Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of five 3-day treatment courses
Max dose
maximum 50 single applications (‘loops’) per session

Contraindications

  • Should not be used on large areas of skin
  • broken skin
  • sensitive skin
  • mucous membranes
  • avoid contact with eyes
  • avoid contact with inside of ears
  • avoid contact with inside of nostrils
  • avoid contact with lips
  • avoid occlusive dressings on treated area
  • Impaired peripheral circulation
  • not suitable for application to face
  • patients with diabetes at risk of neuropathic ulcers
  • significant peripheral neuropathy

Side effects

Common
Headache
Serious
  • Neoplasms

Pregnancy & lactation

Pregnancy

Not absorbed from skin, but manufacturer advises avoid.

Lactation

Not absorbed from skin; ensure infant does not come in contact with treated area for 6 hours after application.

Related guidelines

Other Topoisomerase Inhibitor drugs

Ask House about Podophyllotoxin

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Katzung·Verified: 2026-05-10 · House clinical team